ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 156 filers reported holding ANIKA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,304,057 | -42.7% | 767,797 | -20.1% | 0.00% | -100.0% |
| Q2 2023 | $24,959,142 | -11.5% | 960,706 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $28,208,870 | -3.1% | 982,203 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $29,119,533 | +23.9% | 983,768 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $23,499,000 | +8.0% | 987,368 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $21,767,000 | -12.0% | 975,243 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $24,746,000 | -28.5% | 985,495 | +2.0% | 0.00% | 0.0% |
| Q4 2021 | $34,608,000 | -14.6% | 965,913 | +1.4% | 0.00% | 0.0% |
| Q3 2021 | $40,534,000 | -2.2% | 952,378 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $41,459,000 | +10.4% | 957,701 | +4.0% | 0.00% | 0.0% |
| Q1 2021 | $37,547,000 | -11.2% | 920,498 | -1.5% | 0.00% | 0.0% |
| Q4 2020 | $42,286,000 | +31.1% | 934,282 | +2.6% | 0.00% | 0.0% |
| Q3 2020 | $32,243,000 | -6.4% | 911,036 | -0.2% | 0.00% | 0.0% |
| Q2 2020 | $34,457,000 | +29.1% | 913,243 | -1.1% | 0.00% | 0.0% |
| Q1 2020 | $26,694,000 | -43.8% | 923,365 | +0.8% | 0.00% | -50.0% |
| Q4 2019 | $47,474,000 | -6.0% | 915,596 | -0.5% | 0.00% | 0.0% |
| Q3 2019 | $50,496,000 | +35.7% | 919,959 | +0.4% | 0.00% | +100.0% |
| Q2 2019 | $37,218,000 | +34.8% | 916,258 | +0.3% | 0.00% | 0.0% |
| Q1 2019 | $27,611,000 | -6.6% | 913,076 | +3.8% | 0.00% | 0.0% |
| Q4 2018 | $29,565,000 | -18.6% | 879,651 | +2.1% | 0.00% | 0.0% |
| Q3 2018 | $36,340,000 | +33.2% | 861,569 | +1.0% | 0.00% | 0.0% |
| Q2 2018 | $27,289,000 | -34.4% | 852,770 | +2.0% | 0.00% | -50.0% |
| Q1 2018 | $41,575,000 | -7.6% | 836,172 | +0.1% | 0.00% | 0.0% |
| Q4 2017 | $45,013,000 | -6.5% | 834,970 | +0.6% | 0.00% | 0.0% |
| Q3 2017 | $48,160,000 | +21.0% | 830,348 | +2.9% | 0.00% | 0.0% |
| Q2 2017 | $39,818,000 | +15.8% | 807,039 | +2.0% | 0.00% | 0.0% |
| Q1 2017 | $34,372,000 | -16.9% | 791,242 | -6.4% | 0.00% | 0.0% |
| Q4 2016 | $41,373,000 | +3.9% | 845,044 | +1.5% | 0.00% | 0.0% |
| Q3 2016 | $39,819,000 | -9.2% | 832,155 | +1.8% | 0.00% | -33.3% |
| Q2 2016 | $43,844,000 | +32.2% | 817,224 | +10.2% | 0.00% | +50.0% |
| Q1 2016 | $33,163,000 | +36.0% | 741,576 | +16.1% | 0.00% | 0.0% |
| Q4 2015 | $24,382,000 | -92.2% | 638,962 | -92.2% | 0.00% | -83.3% |
| Q3 2015 | $311,947,000 | +1474.5% | 8,195,877 | +1266.4% | 0.01% | +1100.0% |
| Q2 2015 | $19,812,000 | -27.3% | 599,824 | -9.4% | 0.00% | -50.0% |
| Q1 2015 | $27,264,000 | +2.5% | 662,240 | +1.4% | 0.00% | 0.0% |
| Q4 2014 | $26,597,000 | +18.7% | 652,849 | +6.8% | 0.00% | 0.0% |
| Q3 2014 | $22,401,000 | -11.7% | 611,058 | +11.6% | 0.00% | 0.0% |
| Q2 2014 | $25,366,000 | +30.8% | 547,501 | +16.1% | 0.00% | 0.0% |
| Q1 2014 | $19,389,000 | +7.7% | 471,749 | +0.0% | 0.00% | 0.0% |
| Q4 2013 | $17,998,000 | +83.2% | 471,653 | +15.0% | 0.00% | +100.0% |
| Q3 2013 | $9,823,000 | +39.6% | 409,977 | -1.0% | 0.00% | 0.0% |
| Q2 2013 | $7,037,000 | – | 413,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
| Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
| DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
| Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
| Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
| CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
| Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
| XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |